The pharmaceutical company AstraZeneca operates in more than 100 countries around the world with its headquarters located in Cambridge, United Kingdom. The company’s R&D centers are located in Sweden, USA and England.
In 2008, AstraZeneca Israel was established and today employees over 200 men and women.
AstraZeneca is a global, scientific and innovative company that promotes various solutions for the benefit of the patient, including leading advanced innovative programs around the world.
In Israel, the innovation activity is concentrated under the BeyondBio program which includes an accelerator for mature startups, as well as a partnership in the program to establish new companies in the field of research and development based on artificial intelligence under the company Aion Labs.
AstraZeneca has a long history of excellence in research and development, and focuses on the following core areas:
Oncology, Heart, Vascular and Metabolic diseases, Vaccines, Rare diseases and Respiratory diseases.